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Abstract 
To develop a definition of knee fibrosis occurring after surgery an international panel of 
experts took part in a formal consensus process composed of a discussion phase and three 
Delphi Rounds. Post-surgical knee joint fibrosis was defined as a restricted range of motion 
(ROM), in flexion and/or extension, that is not attributable to osseous or prosthetic block to 
motion from malaligned or mal-positioned or incorrectly sized components, metal hardware, 
ligament reconstruction, infection (septic arthritis), pain, chronic regional pain syndrome 
(CRPS) or other specific causes, but is due to soft tissue fibrosis that was not present pre-
operatively. Movement restriction was graded as mild, moderate or severe according to the 
flexion range (90 to 100°, 70 to 89°, <70°) or extension deficit (5 to 10°, 11 to 20°, >20°). 
Recommended investigations to support its diagnosis and a strategy for patient 
management were also agreed upon. The development of standardised, accepted criteria 
for diagnosis, classification and severity grading of post-surgical knee fibrosis will facilitate 
identification of patients for inclusion in clinical trials, the development of clinical guidelines, 
and eventually to help inform clinical management. 
Introduction  
Joint fibrosis is a well-recognised pathological process that involves diffuse scarring within a 
joint and the surrounding soft tissues leading to restricted joint movement and joint pain 1,2. 
Fibrosis may be a devastating complication following knee surgery that often requires 
further surgical intervention to remove the fibrotic tissue, with resultant surgical morbidity, 
risk of adverse effects and significant risk of recurrence 3-5.  
Tissue from fibrotic knee joints is composed of a dense, disorganised extracellular matrix of 
collagen fibrils 6 interspersed with α-smooth muscle actin containing myofibroblast cells 7. 
Arthroscopy of fibrotic knees has demonstrated well-defined intra-articular fibrous bands 5,8. 
A variety of different clinical criteria have been used to diagnose post-traumatic fibrosis, 
including range of motion (ROM) deficit 9,10 and the presence of fibrotic scar tissue seen at 
operation 5,11,12. The lack of a consistent, widely accepted disease definition is reflected in 
the wide range of incidence reported in the literature for fibrosis post-total knee 
arthroplasty (TKA) as low as 1% 14, or as high as 15%1,5,6,13.  
Furthermore there is no standardised, accepted clinical guideline for the investigation and 
management of knee fibrosis. Consequently, recommendations on the use of computed 
tomography (CT), magnetic resonance imaging (MRI) and ultrasound imaging and the role of 
knee aspiration in diagnosing knee fibrosis are inconsistent 3,5,14. The role and timing of 
treatment, such as manipulation under anaesthesia (MUA), is also debated and several 
different clinical management guidelines have been proposed 3,5,14. 
The lack of a precise definition of post-surgical knee fibrosis presents a challenge for 
research that requires standardised patient selection with a robust diagnosis of knee fibrosis. 
Whilst our understanding of the cellular pathology is progressing, our ability to identify 
affected patients consistently and robustly is hindered by a lack of consensus on diagnostic 
criteria, grading, current role of imaging techniques and treatment options. The aim of this 
study was to develop a definition, diagnostic criteria and classification system for post-
surgical knee fibrosis using a recognised formal consensus process.  
 
Methods  
A Delphi process (brainstorming, narrowing down, quantification) was applied based on 
previously published consensus statements 15 and followed guidelines set out by the NHS 
Research and Development Health Technology Assessment programme 16 and the British 
Medical Journal 17. The consensus process applied here is outlined in Figure 1.  
An expert panel that included knee surgeons, rheumatologists, basic scientists working on 
fibrosis, pathologists and musculoskeletal physiologists was selected based on publication 
record in knee arthroplasty, joint fibrosis, involvement in knee joint fibrosis investigation 
and treatment and willingness to engage in the consensus process. Key individuals involved 
in diagnosis of joint fibrosis 18,19, analysis, management and revision of TKA failure 20, 
investigation and treatment of post-surgical fibrosis 1,5,13,14,21-23, 13,24-32  and basic research on 
fibrosis 33-35 formed the Joint Fibrosis Consensus Working Group. Founding members (SH) 
and Presidents and Past-Presidents of the European Knee Society (JB, JA), the Past-President 
of the International Society of Arthroplasty Registries (OF), members of the Knee Society 
(MM, JN, JB, FH), Head of the Norwegian Knee Arthroplasty Register (OF), Past-President of 
the Arthroplasty Society of Australia (PL), Deputy Director of the Australian Orthopaedic 
Association National Joint Replacement Registry (PL), and members of the British 
Association for Knee Surgery Research Board (AT) were part of the Group. Previous 
participants in an international consensus group on prosthetic joint infection (MM, FH, RMJ) 
were also included. Several members have also Chaired instructional courses for knee 
stiffness and contracture management (MM, AB, PL).  
In the first step of the process members of the working group identified specific topics that 
required consensus formation (brainstorming). A literature review was undertaken (NK) 
focusing on key areas requiring consensus and circulated to the panel for comments.  A 
search was done of Medline (via PubMed), Embase and Cochrane databases for papers on 
knee fibrosis. Only reports in English were included that were published between 1950 and 
June 2015. These studies formed the start of the Delphi process. The following search terms 
were used: ‘arthrofibrosis’, ‘fibrosis’, ‘knee’, ‘arthroplasty’, ‘knee replacement’, ‘ligament 
reconstruction’. Overall 320 papers were reviewed and information on key topics (definition, 
classification, diagnosis, investigation, management) from 47 reports was circulated to the 
group. Feedback from the panel was used to define key areas for consensus and to draft 
initial statements (NK, DJD).  
Draft consensus statements were circulated for rating by use of a scale of 1 (disagree) to 10 
(agree), and comments. An online survey tool (www.sosci.de) was used throughout the 
Delphi process. These inputs were integrated and the amended consensus statements were 
prepared with a detailed explanation for each revision. Anonymised results from the first 
round were then recirculated for scoring, comments, and proposed revisions for statements 
that scored 7 or less in the first round. Three rounds were required before final revisions 
were derived. A predetermined mean score of 7 or more (with three or fewer outliers: 
defined as scores less than 4) was used to define consensus. 
Results – Consensus Findings  
Consensus was reached on 24 statements that fulfilled the criteria for acceptance. These 
statements were grouped into eight key categories (Definition and Classification, 
Investigations, Diagnosis etc.).  
Definition and Classification of the Condition  
Post-surgical knee joint fibrosis was defined as restricted knee joint ROM, in flexion and/or 
extension, that is not attributable to bony or prosthetic block to motion from malaligned or 
mal-positioned components, metal hardware, ligament reconstruction, infection (septic 
arthritis), pain, CRPS or other specific causes, and is due to soft tissue fibrosis that was not 
present pre-operatively. Pain is a possible cause of stiffness; this can be demonstrated by 
examination under anaesthesia. The term post-surgical knee fibrosis was selected by the 
panel, rather than arthrofibrosis, which is commonly used in the literature, as a precise 
name for the deposition of fibrotic scar tissue in the knee joint following surgery. Post-
surgical knee fibrosis encompasses ligament reconstruction and arthroplasty surgery. 
Fibrosis following trauma was considered as a separate condition. It was recognised that 
knee fibrosis may be primary (spontaneous), if it occurs without a preceding traumatic injury, 
joint infection, or surgical procedure, but the overwhelming majority of knee fibrosis occurs 
following either trauma, infection (septic arthritis) or surgery (secondary). The classification 
of knee fibrosis as primary or secondary reflects this consensus (Figure 2).  
 Investigations  
The principal aim of investigation in a patient with a stiff, painful knee and suspected fibrosis 
following surgery is to exclude other causes of stiffness. These include, but are not 
exclusively limited to, osseous or prosthetic block to motion from mal-positioned or 
incorrectly sized components, metal hardware, ligament reconstruction or infection or CRPS. 
Plain films and CT scans are useful for identifying component mal-positioning or a bony block 
to motion, such as heterotopic ossification. Infection must be excluded and laboratory 
evaluation of blood inflammatory indicators (C-reactive protein), cell count and differential, 
as well as aspiration of the joint for microbiological culture and cell count is strongly 
recommended. Criteria set out by the Musculoskeletal Infection Society (MSIS) should be 
used to rule out infection 36. Aspiration of stiff knee joints may not find fluid available; in this 
situation injection of saline and re-aspiration is not recommended in the Philadelphia 
Consensus Meeting on periprosthetic joint infection 37,38.  
A number of painful and stiff knees post TKA are related to wrong indication with no bone-
on-bone disease 39. Evaluation of preoperative x-ray images makes the diagnosis in these 
cases without the need for further sophisticated assays.  
Consensus Statements – Definition and Classification 
 Post-surgical knee joint fibrosis is defined as restricted ROM, in flexion or 
extension, that is not attributable to osseous or prosthetic block to motion from 
mal-positioned or incorrectly sized components, metal hardware, ligament 
reconstruction, infection (septic arthritis), pain, CRPS or other specific causes, and 
is due to soft tissue fibrosis that was not present pre-operatively 
 Joint fibrosis may be spontaneous (primary) or following an insult such as surgery 
or trauma (secondary) 
 Spontaneous knee joint fibrosis, in the absence of trauma or surgery, is extremely 
rare. Post-trauma or post-surgery knee fibrosis is much more clinically important 
 This classification can be further sub-categorised into post-arthroplasty joint 
fibrosis, post-ligament reconstruction fibrosis etc., according to the algorithm in 
Figure 2  
In addition to intra-articular scarring, a fibrotic or non-elastic extensor mechanism can result 
in knee stiffness and pain. Evaluation of pre-operative x-ray images can be used to find 
evidence for extensor mechanism disease. Removal of intra-articular scarring will be 
ineffective in restoring knee motion in these cases.  
Fibrosis may be present with other causes of knee pain and stiffness post-surgery, and may 
be triggered by them (e.g. by infection or mechanical conflict). When fibrosis occurs 
alongside another pathology causing stiffness, this was not considered true post-surgical 
knee fibrosis. 
At present fibrosis cannot yet be robustly diagnosed by MR imaging but it may be useful in 
the future as metal artifact reducing scan sequences are being developed for this purpose. In 
the future the basis of MR objective measurements of fibrosis could be the quantification of 
fibrotic tissue in the knee joint, such as in the parapatellar gutters, or the measurement of 
perisynovial thickness.  
 
 
Diagnosis  
Post-surgical knee fibrosis is a clinical diagnosis that can only be made when investigations 
have been performed to exclude other causes. The clinical diagnosis may be supported by 
Consensus Statements – Investigations 
 There is no definitive diagnostic imaging test available for diagnosing post-
surgical knee fibrosis 
 Knees should be investigated by plain radiographs (which may show patella 
infera). CT scans can help identify component mal-positioning 
 The purpose of x-ray and CT imaging is to rule out causes of stiffness post-
surgery (e.g. implant malalignment, component sizing issues). There is 
currently not enough evidence for the routine use of MRI in diagnosing 
fibrosis  
 We propose an algorithm for investigation of patients with stiff knee joints 
post-surgery (Figure 3)  
direct visualisation of fibrosis at surgery, either arthroscopically or by open techniques. 
Laboratory evaluations and aspiration for microbiological culture should be performed 
routinely to rule out infection according to the Musculoskeletal Infection Society (MSIS) 
criteria 36. Bone scan alone is not recommended to rule out infection. Histological criteria 
have been proposed 18,19, but biopsy to make a diagnosis is not required. Tissue taken at the 
time of débridement may be sent for histopathological evidence of fibrosis to support the 
diagnosis.  
 
 
Range of knee motion  
Reduction in flexion and/or extension is required for a diagnosis of joint fibrosis. The severity 
of ROM loss can be graded according to the amount of restricted movement. This criterion is 
active rather than passive ROM, as examiners may apply varying degrees of pressure. For 
simplicity, an absolute ROM is used for grading of severity. Comparison with pre-operative 
ROM and with the contralateral knee may be useful clinically, but these comparisons can be 
affected by pre-operative stiffness and the presence or absence of contralateral disease. The 
goal of TKA includes establishment of ROM, therefore absolute ROM restriction forms part 
Consensus Statements – Diagnosis  
 A clinical diagnosis of joint fibrosis may be made after excluding other causes 
of stiffness 
 The clinical diagnosis may be confirmed surgically (either through open or 
arthroscopic visualisation of the joint), but surgery is only warranted as an 
intervention and is not justified for diagnosis alone 
 Tissue biopsy is not required to make the diagnosis 
 Further research into radiological measures of fibrosis (e.g. perisynovial tissue 
thickness, knee circumference) is required before their widespread use in 
diagnosis 
 Further research is required to identify robust predictors of joint fibrosis. 
These may include serum biomarkers  
of the criteria for the diagnosis of joint fibrosis. Three levels of severity were agreed 
according to the movement restriction (mild, moderate and severe). Extreme ROM loss, with 
global ROM <30° in total, that may happen in knee ankylosis following septic arthritis as 
described by Bae et al. (2005) 40, does not form part of the severity classification for post-
surgical knee fibrosis. The severity of knee fibrosis is not solely due to the degree of ROM 
limitation and other factors are important, including pain.  
 
 
Pathological Anatomy  
Information on the patho-anatomical location can be gained from clinical examination and 
correlation with areas of swelling or particular ROM deficit. However, direct visualisation is 
the gold standard for determination of the location of fibrosis. MRI may in the future 
become a useful tool for identifying areas of fibrosis. Focal fibroses such as infra-patella 
contraction syndrome (IPCS) 41 do not generally cause severely restricted ROM. Thorpe et al. 
describe a syndrome of painful patellofemoral dysfunction, but not ROM restriction, 
following TKR in 11/635 patients 42. Intra-articular lesions were found transversely on the 
patella, or running between the patella and the fat pad or the intercondylar notch. 
Arthroscopic removal of the lesions resolved patient’s symptoms without a change in their 
active ROM. Without an ROM restriction these lesions do not form part of the disease 
definition of post-surgical knee fibrosis. 
 
 
 
Consensus Statements – Range of motion Restriction 
 A restricted range of motion in flexion or extension, or both flexion and 
extension must be present for a diagnosis of knee joint fibrosis 
 The severity may be graded according to motion loss based on the deviation 
from full flexion or extension as mild, moderate and severe extension 
restriction (5-10°, 11-20°, >20°) or flexion range (90-100°, 70-89°, <70°).  
  
 
Histopathology  
Criteria for a tissue diagnosis have been proposed 18,19. Histopathologically post-surgical 
knee joint fibrosis is characterized by a varying degree of fibrosis (cellularity of fibroblasts) 19. 
In one report a count of beta-catenin positive cells above a set threshold level (>20 per high 
power field, 0.307mm2) allows, in conjunction with the clinical information, the 
histopathological diagnosis of arthrofibrosis. Histopathological analysis of tissue taken 
during surgery performed to débride fibrotic lesions responsible for reduced ROM is useful 
to support the diagnosis, but biopsy is not required for diagnosis, particularly as it requires 
an invasive procedure that may cause infection. 
Consensus Statements – Pathoanatomy  
 The anatomical location of fibrosis can be demonstrated during open or 
arthroscopic surgery. Current imaging modalities (e.g. USS, MRI) are not yet 
validated for visualising fibrosis  
 The location of the scar tissue may be as follows:  
o Infrapatellar (Hoffa) fibrosis  
o Medial or lateral parapatellar fibrosis or scarring (gutter) 
o Suprapatellar pouch fibrosis, scarring or obliteration 
o Patella tendon shortening 
o Posterior fibrosis 
o Quadriceps muscle fibrosis/scarring (vastus intermedius) 
o Intrasubstance fibrosis of the knee joint capsule,  
o Diffuse fibrosis or scarring involving a combination of the above 
 Local fibroses such as infrapatellar contraction syndrome or discrete bands of 
adhesions that do not cause restricted range of motion are not sufficient for a 
diagnosis of Knee Joint Fibrosis, and are considered Local Fibrosis 
 Prevention and Management  
There is some evidence that aggressive physical rehabilitation regimens can reduce the 
incidence of fibrosis, but in some patients this may actually precipitate or worsen fibrosis. 
Some evidence exists that optimised post-operative pain control can reduce the 
requirement for subsequent MUA post-TKA 43. Pharmaceutical modulation of inflammation 
with corticosteroids 44 and the interleukin-1 receptor antagonist Anakinra 45 has been used 
to reduce the inflammatory response and decrease fibrotic tissue formation  and pain 46 post 
operatively. Further research is required to optimise the post-surgical recovery period to 
reduce the incidence of fibrosis.   
Management of fibrosis depends on the stage. Early fibrosis, which often has a ‘soft end-
point’ to knee motion, may be treated successfully with physical therapy and manipulation. 
Analgesic therapy and relaxation techniques may also be helpful 47. In addition mechanical 
soft tissue stimulation using instruments such as Astym have shown early results in stiff TKA 
27. Established fibrosis, typically present after three to six months post-surgery, often has a 
hard end-point to knee motion. There is some evidence that MUA performed within three 
months post-surgery is more effective than that performed after three months 23,48. Use of 
MUA should be considered alongside risk of iatrogenic fracture, particularly in patients with 
inflammatory conditions such as rheumatoid arthritis. Timing of MUA was debated within 
the group, with some members feeling that MUA is safe and effective up to six months post-
surgery. This debate is reflected in the range of time post-surgery that MUA is considered an 
option (three to six months) although it is emphasised that effort should be made to exclude 
other causes of stiffness as early post-operatively as possible to allow MUA to be performed 
before fibrosis becomes established. 
MUA should be performed at the time of maximum muscle relaxation by flexing the hip to 
90 and grasping the tibia proximally to avoid leverage on the joint. The knee is flexed slowly 
and gently until palpable and audible separation of adhesions no longer occurs (as described 
Consensus Statements – Histopathology  
 Further research is needed to determine a histological definition of fibrosis 
by Fox et al.49). Consensus was reached that established fibrosis requires arthroscopic or 
open débridement. Revision of the implant may be required to re-establish ROM. 
 
 
 
Joint registries and fibrosis  
Joint replacement registries do not currently allow sufficiently granular identification of 
patients with post-surgical knee fibrosis. ‘Arthrofibrosis’ or stiffness is often used as an 
umbrella term for stiff knees, lack of movement and true fibrosis, making it difficult to define 
true fibrosis cases. Furthermore, procedures for treating fibrotic stiffness, such as MUA and 
arthroscopic débridement, where open surgery is not performed and components are not 
changed, are not recorded in most registries.  
 
Consensus Statements – Prevention and Management  
 Early fibrosis, <3 to 6 months post-operatively, may respond to treatment 
with physiotherapy and rehabilitation therapy and manipulation under 
anaesthesia (MUA), whereas established, ‘late’ fibrosis is relatively resistant 
to physical therapy and MUA  
 Some evidence exists that successful post-operative pain control can reduce 
the incidence of post-surgical knee fibrosis 47, although further research into 
prevention of post-surgical knee joint fibrosis is required  
 Further research is required to develop an evidence-based management 
algorithm to prevent post-surgical joint fibrosis 
 We propose an algorithm for management of diagnosed post-surgical knee 
joint fibrosis (Figure 4) 
Consensus Statements – Joint Registries  
 Registries in their current form do not provide a robust resource for 
identifying patients who have post-surgical joint fibrosis due to a range of 
different limitations, including lack of a current, accepted disease definition 
and diagnostic criteria and most national registries do not include 
reoperations without component removal or change or closed procedures 
Discussion 
This international consensus provides agreement amongst a multidisciplinary panel for the 
definition, classification and diagnostic criteria of post-surgical knee fibrosis. Knee fibrosis is 
defined as a clinical diagnosis characterised by restricted knee ROM. The severity of fibrosis 
may be grouped according to the degree of ROM restriction and a grading scale is proposed. 
The diagnosis may be supported by direct visualisation of fibrosis at surgery and by 
histopathological analysis of knee tissue, although formal biopsy is not indicated or required.  
Post-surgical knee fibrosis presents both a diagnostic and therapeutic clinical challenge. It is 
considered a clinical diagnosis of exclusion that requires thorough investigation to prove 
that stiffness and pain is not due to another cause. The list of possible causes of post-
surgical knee stiffness is long, but infection and component malalignment or technical 
surgical error in particular must be excluded. Investigation algorithms have been presented 
for the analysis of the failed TKA 50. A significant proportion of failed TKAs are due to 
malrotation of implanted components, and this must absolutely be ruled out before making 
a diagnosis of fibrosis 51. The cornerstones of investigation remain a directed clinical 
examination, knee aspiration and laboratory evaluation to rule out infection, and plain films 
and CT scan to analyse implant position 3. MRI scan with artifact reducing sequences may in 
the future provide a non-invasive method to describe intra-articular fibrosis.  
Fibrosis may co-exist with other conditions and may be triggered by them, such as following 
trauma or mechanical conflict caused by component malalignment 52. Fibrosis in this context 
was not considered post-surgical knee fibrosis, which currently has an unknown aetiology. 
Tissue from arthrofibrotic joints is composed of a dense, disorganised extracellular matrix of 
collagen fibrils 6 interspersed with α-smooth muscle actin containing myofibroblast cells 7 
which form intra-articular fibrous bands 5,8. The molecular mechanism underlying the 
development of post-traumatic fibrosis is not known. It is likely that different triggers 
converge on a common ‘fibrotic pathway’ 53, involving myofibroblasts 7 and TGF-
54. Furthermore, there is some evidence that fibrotic type conditions are 
heritable33.  
The patho-anatomic location of the fibrosis may be a range of different locations for a 
diagnosis of fibrosis, but must be sufficient to cause movement restriction. Limited 
pathology in local fibroses that do not cause ROM restriction such as infra-patella 
contraction syndrome is not considered knee fibrosis.  
Alongside imaging investigation aspiration of the knee is recommended to rule out infection. 
Provided this is performed in sterile conditions the risk of introducing infection is 
outweighed by the need to establish whether stiffness is due to infection. Histopathology 
may be used to support the diagnosis of fibrosis, and recent publications have provided 
diagnostic criteria, such as the number of beta-catenin staining cells, but these criteria need 
validation before biopsy can be recommended to establish a diagnosis 18,19. 
There was considerable debate over ROM restriction and whether this should be measured 
against pre-operative values or against the contralateral knee. Several grading systems have 
been proposed 9,10,55. Agreement was reached on grading severity by absolute ROM 
restriction irrespective of pre-operative stiffness or ROM of the contralateral knee. The 
limitation of the chosen grading is that knees with reduced ROM pre-operatively often do 
not regain ROM post TKA. The important message is that some degree of motion restriction 
in either flexion, extension, or both is absolutely required for a diagnosis of post-surgery 
joint fibrosis. It is also important to note that to judge success solely on ROM achieved 
would miss the main reason for TKA, namely pain reduction.  
Rehabilitation protocols aimed at restoring ROM have reduced incidence of stiffness post-
surgery, particularly following ACL reconstruction 13,47,56,57, but the optimum regimen 
remains unknown. Similarly, management of the stiff TKA remains challenging and evidence 
for particular treatment approaches is not available. There is limited evidence that 
optimised pain control can reduce the requirement for MUA in stiff knees post-TKA 43. Good 
analgesia should form part of the management plan for patients undergoing TKA. One 
critical concept in the approach to fibrosis is of early versus late disease. The fibrotic 
condition is a disease spectrum, and early fibrosis often has a soft end-point to motion and 
will be amenable to physical therapy and manipulation. Conversely, established fibrosis, 
which likely occurs after 3 to 6 months, often has a hard end-point to knee motion. It is 
refractory to physical therapy and manipulation runs the risk of iatrogenic fracture and 
should be avoided48. There was considerable debate over the timing of MUA post-surgery. A 
consensus that MUA more than six months post-surgery was not indicated, but between 
three and six months some members felt MUA was appropriate. There is limited evidence 
that MUA is most effective less than three months from surgery 23. The timescale for MUA 
was left deliberately open and consensus was reached on a statement that MUA may be 
considered up to three to six months post-surgery. 
Patients resistant to non-operative treatment require arthroscopic or more invasive surgical 
procedures to excise and remove the soft tissue contractures 3. In knee disease, arthroscopic 
release may be used as an initial approach of choice. Kim et al. (2004) provide a treatment 
algorithm for arthroscopic débridement involving capsular distension with fluid, medial and 
lateral retinacular releases, graft débridement and posterior joint release 4. Open surgery for 
fibrosis is reserved for knees resistant to conservative or arthroscopic procedures (2% of 
cases) 58 and often requires large incisions with extensive surgical exploration of the joint 
and surrounding extra-capsular soft tissues 12. The outcomes of surgically treated post-
traumatic fibrosis of the knee are poor, with most patients unable to return to pre-injury 
level of function 12,59. Currently, available treatments work by stretching or surgically 
removing the fibrotic tissue; they do not address the biological basis of disease. This may 
contribute to recurrence of post-traumatic fibrosis, which is a frequent problem 5,10.   
The role of joint replacement registries in fibrosis research was considered. Population level 
studies of patients with fibrosis would allow identification of risk factors, provide more 
precise incidence data, and inform management strategies. Currently, robust identification 
of patients with fibrosis in National Registries is challenging; arthrofibrosis as a reason for 
revision forms one group in the Australian registry, while the UK registry uses stiffness, 
despite the range of different pathologies that this encompasses. Furthermore, only patients 
having a formal revision procedure involving exchange, removal or insertion of components 
are captured by registries, significantly underestimating the number of patients with fibrosis 
who are treated with non-operative measures or débridement only. A way forward for 
registries might be to use this consensus statement as a definition and include joint fibrosis 
post TKA as a revision cause and also include open revision procedures not involving implant 
components and closed procedures such as MUA. 
This consensus process has provided a definition, classification and diagnostic criteria for 
knee fibrosis post-surgery. The aim was not to provide a clinical guideline on the 
management of these patients, because further research into the prevention and 
management of knee fibrosis is required. These statements should now undergo a period of 
validation to allow this definition and classification system to be improved upon and 
modified. 
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8 Topics
Definition 
Investigations 
Diagnosis
Range of Motion 
Pathoanatomy
Histopathology 
Management 
Joint Registries
Knee Joint Fibrosis
Primary*
No causative insult identified
*Extremely rare in the knee
Secondary
Initiating factor identified
Following Traumatic 
Injury or Infection
Post-surgery
Post-arthroplasty Post-ligament 
Reconstruction or other procedure
Local Generalised Local Generalised
Post-surgery Stiff knee
Investigation Algorithm
Clinical examination
Measure ROM 
(active versus passive)
Test patellar mobility 
Test quadriceps action 
Test joint stability 
Exclude 
Chronic Regional Pain Syndrome
Infection, wound issues, wrong surgical indication
Problems with implant (mal-positioning, cement, ectopic bone formation (rare), loosening, mal-alignment)
History
Pain control after surgery inadequate?
Rehabilitation followed? 
Investigations
1. Imaging 
Plain XRs – heterotopic ossification, patella infera
CT scan – component malalignment
2. Serology 
Inflammatory markers
3. Aspiration 
To rule out infection
Additional Optional Tests 
1. Histology
Biopsy to demonstrate scar tissue
2. MRI – scar tissue
**NOTE THAT NOT ALL INVESTIGATIONS ARE MANDATED, 
CLINCAL JUDGEMENT IS REQUIRED AND THE DIAGNOSIS MAY BE 
MADE CLINICALLY WITH SUPPORT OF PLAIN RADIOGRAPHS**
Diagnosis of Post-surgery knee fibrosis may be made
Post-surgery Knee Joint Fibrosis
Management and Treatment Algorithm
>6 Months Post-op
Late Fibrosis
ROM not improved
<3-6 Months Post-op
Early Fibrosis
Cases may respond to non-operative 
measures*
Physiotherapy, stretching, movement exercise, relaxation 
techniques
Static progressive splints
Trial of non-operative measures*
Physiotherapy, stretching, movement exercise, relaxation 
techniques
Static progressive splints
ROM improved
Surgical Procedure
First line – arthroscopic 
Second line – open debridement to restore ROM, 
may require revision of TKR
MUA
ROM improved
*Important to work up patient to exclude causes of stiff TKR whilst non-operative treatments are employed
ROM not improved
